The DOI matches its OpenAlex record; 22 of the 22 references it cites were found in a registry or an index.
Neuropsychologic Impact of Standard-Dose Systemic Chemotherapy in Long-Term Survivors of Breast Cancer and Lymphoma
Abstract
PURPOSE: The primary purpose of this study was to compare the neuropsychologic functioning of long-term survivors of breast cancer and lymphoma who had been treated with standard-dose systemic chemotherapy or local therapy only. PATIENTS AND METHODS: Long-term survivors (5 years postdiagnosis, not presently receiving cancer treatment, and disease-free) of breast cancer or lymphoma who had been treated with systemic chemotherapy (breast cancer: n = 35, age, 59.1 +/- 10.7 years; lymphoma: n = 36, age, 55.9 +/- 12.1 years) or local therapy only (breast cancer: n = 35, age, 60.6 +/- 10.5 years; lymphoma: n = 22, age, 48.7 +/- 11.7 years) completed a battery of neuropsychologic and psychologic tests (Center for Epidemiological Study-Depression, Spielberger State-Trait Anxiety Inventory, and Fatigue Symptom Inventory). RESULTS: Multivariate analysis of variance, controlling for age and education, revealed that survivors who had been treated with systemic chemotherapy scored significantly lower on the battery of neuropsychologic tests compared with those treated with local therapy only (P <.04), particularly in the domains of verbal memory (P <.01) and psychomotor functioning (P <.03). Survivors treated with systemic chemotherapy were also more likely to score in the lower quartile on the Neuropsychological Performance Index (39% v 14%, P <.01) and to self-report greater problems with working memory on the Squire Memory Self-Rating Questionnaire (P <.02). CONCLUSION: Data from this study support the hypothesis that systemic chemotherapy can have a negative impact on cognitive functioning as measured by standardized neuropsychologic tests and self-report of memory changes. However, analysis of the Neuropsychological Performance Index suggests that only a subgroup of survivors may experience long-term cognitive deficits associated with systemic chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The CES-D Scale: A Self-Report Depression Scale for Research in the General Population
Radloff, L. S. (1977) · Applied Psychological Measurement · doi:10.1177/014662167700100306 · Cited by 53,267
(1970) · Cited by 24,983
Kaplan, E., Goodglass, H., Weıntraub, S., & Segal, O. (2001) · Medical Entomology and Zoology · Cited by 4,378
van Dam, F. S. A. M., Boogerd, W., Schagen, S. B., Muller, M. J., Droogleever Fortuyn, M. E., Wall, E. V. D., & Rodenhuis, S. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.3.210 · Cited by 763
Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma
Schagen, S. B., van Dam, F. S. A. M., Muller, M. J., Boogerd, W., Lindeboom, J., & Bruning, P. F. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990201)85:3<640::aid-cncr14>3.0.co;2-g · Cited by 620
Cognitive Function in Breast Cancer Patients Receiving Adjuvant Chemotherapy
Brezden, C. B., Phillips, K.-A., Abdolell, M., Bunston, T., & Tannock, I. F. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.14.2695 · Cited by 557
Mayo's older americans normative studies: WAIS-R norms for ages 56 to 97
Ivnik, R. J., Malec, J. F., Smith, G. E., Tangalos, E. G., Petersen, R. C., Kokmen, E., & Kurland, L. T. (1992) · Clinical Neuropsychologist · doi:10.1080/13854049208401877 · Cited by 446
Development of an intervention to restore attention in cancer patients
Cimprich, B. (1993) · Cancer Nursing · doi:10.1097/00002820-199304000-00001 · Cited by 376
Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer
Wieneke, M. H., & Dienst, E. R. (1995) · Psycho-Oncology · doi:10.1002/pon.2960040108 · Cited by 317
Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer
Ahles, T. A., & Saykin, A. (2001) · Cancer Investigation · doi:10.1081/cnv-100107743 · Cited by 213
Self-citationIntroduction to Cognitive Rehabilitation
Sohlberg, M., & Mateer, C. (1990) · Journal of Head Trauma Rehabilitation · doi:10.1097/00001199-199009000-00017 · Cited by 207
Memory complaint after electroconvulsive therapy: assessment with a new self-rating instrument.
Squire, L. R., Wetzel, C., & Slater, P. C. (1979) · PubMed · Cited by 198
Neurocognitive dysfunction in cancer patients.
Meyers, C. A. (2000) · PubMed · Cited by 170
Estrogen and Cognitive Functioning in Women
Sherwin, B. B. (1998) · Experimental Biology and Medicine · doi:10.3181/00379727-217-44200 · Cited by 166
Quality of life among long-term cancer survivors.
Ferrell, B. R., & Dow, K. H. (1997) · PubMed · Cited by 155
Mayo's older americans normative studies: WMS-R norms for ages 56 to 94
Ivnik, R. J., Malec, J. F., Smith, G. E., Tangalos, E. G., Petersen, R. C., Kokmen, E., & Kurland, L. T. (1992) · The Clinical Neuropsychologist · doi:10.1080/13854049208401879 · Cited by 147
Hann, D. M., Jacobsen, P. B., Martin, S. C., Kronish, L. E., Azzarello, L. M., & Fields, K. K. (1997) · Supportive Care in Cancer · doi:10.1007/bf01681961 · Cited by 117
Ahles, T. A., Silberfarb, P. M., Herndon, J. E., Maurer, L. H., Kornblith, A. B., Aisner, J., Perry, M. C., Eaton, W. L., Zacharski, L., Green, M. R., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.5.1954 · Cited by 114
Self-citationNormative neuropsychological test performance: effects of age, education, gender and ethnicity.
Saykin, A., Gur, R. C., Gur, R., Shtasel, D., Flannery, K., Mozley, L., Malamut, B., Watson, B., & Mozley, P. (1995) · Applied Neuropsychology · doi:10.1207/s15324826an0202_5 · Cited by 103
Self-citationCalifornia verbal learning test: Normative data for the elderly
Paolo, A. M., Tröster, A. I., & Ryan, J. J. (1997) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/01688639708403853 · Cited by 68
Saykin, A. J., Janssen, R. S., Sprehn, G. C., Kaplan, J. E., Spira, T. J., & O'Connor, B. (1991) · Journal of Neuropsychiatry · doi:10.1176/jnp.3.3.286 · Cited by 47
Self-citationMcAllister, T. W., Sparling, M. B., Flashman, L. A., Guerin, S. J., & Saykin, A. J. (2000) · NeuroImage · doi:10.1016/s1053-8119(00)91103-0 · Cited by 1
Self-citation
Research works printed but not linked: 2
- 10.1016/0360-3016(95)00026-U · doi:10.1016/0360-3016(95)00026-u
- 10.3928/0048-5713-19890701-09 · doi:10.3928/0048-5713-19890701-09
Cited by
Cancer treatment and survivorship statistics, 2012
Siegel, R., DeSantis, C., Virgo, K., Stein, K., Mariotto, A., Smith, T., Cooper, D., Gansler, T., Lerro, C., Fedewa, S., et al. (2012) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21149 · Cited by 2,928
Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology
Gradishar, W. J., Anderson, B. O., Balassanian, R., Blair, S. L., Burstein, H. J., Cyr, A., Elias, A. D., Farrar, W. B., Forero, A., Giordano, S. H., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0012 · Cited by 1,609
Wefel, J. S., Vardy, J., Ahles, T., & Schagen, S. B. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70294-1 · Cited by 998
Self-citationCandidate mechanisms for chemotherapy-induced cognitive changes
Ahles, T. A., & Saykin, A. J. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2073 · Cited by 916
Self-citationCancer Survivors in the United States: Age, Health, and Disability
Hewitt, M., Rowland, J. H., & Yancik, R. (2003) · The Journals of Gerontology Series A: Biological Sciences and Medical Sciences · doi:10.1093/gerona/58.1.m82 · Cited by 785
Metadata
- Authors
- Ahles, T. A., Saykin, A. J., Furstenberg, C. T., Cole, B., Mott, L. A., Skalla, K., Whedon, M. B., Bivens, S., Mitchell, T., Greenberg, E. R., & Silberfarb, P. M.
- Venue
- Journal of Clinical Oncology
- Published
- 2002-01-15
- Volume
- 20
- Issue
- 2
- Pages
- 485-493
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2098757634
- Cited by
- 736
- References
- 22
- FWCI
- 26.08
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.